The primary tumors of many metastatic cancers display increased expression of key proteins involved in invadopodia formation (e.g. Tks5, EGFR), compared to non-metastatic cancers (6–8). The gene discussed is SH3PXD2A; the disease is metastatic malignant neoplasm.